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Effects of photoinitiators on intracellular signaling transduction 
Natasha D. Sheybani, Leyuan Xu, Hu Yang 
Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, VA 23284 
ABSTRACT 
  
 Photopolymerization has been widely explored in biomedical and tissue 
engineering applications due to its widely held potentials in the biomedical 
field.  Photoinitiators embedded within crosslinked scaffold materials could potentially 
serve as a more effective alternative to present uses of gamma radiation for 
sterilization of implants and biomaterials.  The purpose of this study was to evaluate 
the cellular toxicity and the intracellular response of three ultraviolet (UV) sensitive 
photoinitiators including eosin Y, 2-hydroxy-1-[4-(hydroxyethoxy)phenyl]-2methyl-1-
propanone (Irgacure 2959) and dimethoxyphenyl acetophenone (DMPA) as well as 
the subsequent degree of proliferation of free radicals on HN4 cells.  WST-1 assay 
indicated that HN4 cells can tolerate a wide range of concentrations of eosin Y and 
low concentrations of Irgacure 2959 (≤ 1 mg/ml) but not DMPA.  Consistent with these 
results, eosin Y displayed no effect on intracellular AKT inactivation, but both Irgacure 
2959 and DMPA concentration-dependently induced intracellular AKT inactivation.  To 
initiate free radicals, these photoinitiators were exposed to UV light at 365 nm with an 
intensity of 100 watts for 30 minutes.  In all three photoinitiating systems, HN4 cells 
failed to maintain cell viability and intracellular AKT activity.  To further demonstrate 
the stability of free radicals on cytocompatibility, cell culture medium was mixed with 
eosin Y to reach a final concentration of 25μl/ml, and this mixture was exposed to UV 
light for 30 min.  The mixture was kept in the dark prior to exposure to the cells.  The 
results illustrate that the free radicals can be stable up to 48 hours, and HN4 cells 
failed to maintain cell viability and intracellular AKT activity in the eosin Y 
photoinitiating system after UV exposure.  In summary, these results suggest that 
eosin Y is able to stabilize intracellular AKT activity and cell viability in a wider range 
than Irgacure 2959 and DMPA.  However, the free radicals introduced by UV light 
significantly inhibit intracellular AKT activation and induce cytotoxicity.  Future studies 
will aim to overcome the cruciality of removing from or significantly limiting free 
radicals within the photopolymer before biomedical applications. 
 
 
 
 
 
 
 
 
 
CONCLUSIONS 
 
Results indicate that among the three photoinitiators tested, Eosin Y proved to posses properties supported cell viability and stable 
intracellular AKT activity on the most optimal range. However, the stable presence of free radicals induced by photoinitiators 
causes a failure of HN4 cells to maintain cell viability and intracellular AKT activity.  This effect was observed even in the eosin Y 
photoinitiating system after UV exposure; it is thus vital that free radicals be completely removed and limited before application to 
biomaterials.  Future studies will be specifically directed towards development and synthesis of a targeted anti-cancer drug 
delivery system incorporating a designated concentration of the photoinitiator for polymerization of cells without detrimental effects 
of free radicals. 
 
 
   
 
  
METHODS 
 
Photoinitiator preparation  
• DMPA and Irgacure 2959 stock solutions:  0, 25, 50, 100, 250 and 500 mg DMPA and Irgacure 2959 separately dissolved in 1 ml of ethanol  
• Eosin Y stock solution:  0.1% eosin Y, 4% NVP, and 40% TEOA in PBS  
• All resulting photoinitiator solutions protected from light and stored at room temperature until use 
 
Cell culture  
HN4 cells derived from a primary SCC of the head and neck cultured in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with high 
glucose, L-glutamine, 10% (v/v) fetal bovine serum,100 units/ml of penicillin and 100 μg/ml of streptomycin at 37°C in a humid environment 
with 5% CO2 prior to any biocompatibility studies 
 
Comparison of photoinitiators  
• Cell seeding at density of 50,000 cells/well in 3 ml of cell culture media,  
• At 80-90% cell confluence, 40 μl of each DMPA or Irgacure 2959 stock solution added to the culture media to reach a final concentration of 
0, 0.5, 1, 2, 5 and 10 mg/ml of each photoinitiator.   
• 0, 5, 10, 20 and 40 μl Eosin Y stock solution added to the culture media to reach a final concentration of 0, 2.5, 5, 10 and 20 μl/ml of Eosin Y 
• Incubation at 37°C for 30 min prior to harvesting by total cell lysate buffer with protease and phosphatase inhibitors 
 
Western blot analysis 
•  Total cellular protein expression analyzed for p-AKT, AKT1, and β-actin by standard procedures  
•  Density of immunoblot bands analyzed using Image J software 
 
Cellular proliferation rate  
• Cell seeding at density of 10,000 cells/well and cultured for 2 days to allow the cells adhesion.  
• Spent media replace daily with fresh media containing different photoinitiator concentrations  
• Incubation with 10% (v/v) 0f WST-1 reagent 
• Absorbance measured at 450 nm against a background control as a blank and resulting value subtracted by the absorbance at 650 nm 
(reference wavelength) 
 
Comparison of photoinitiators after UV exposure  
• Fresh cell culture media and photoinitiator stock mixtures at concentrations of 0, 0.5, 1, 2 mg/ml of DMPA and Irgacure 2959 as well as 0, 
2.5, 5, 10 μl/ml of Eosin Y 
• Exposure to UV radiation at 325 nm for 30 min for derivation of free radicals   
• Subjection of HN4 cells to the post-UV treated media for 30 min 
• Western blot analysis of total cellular p-AKT and AKT1 expression 
• WST-1 assay to determine cellular proliferation rate 
 
Cytotoxicity and cellular response of free radicals  
• Fresh cell culture media and Eosin Y stock mixtures at final concentration of 20 μl/m 
• Exposure to UV radiation at 325 nm for 30 min for derivation of free radicals   
• Subjection of HN4 cells to the post-UV treated media for 30 min after dark resting states of 0, 6, 24, 48 hrs  
• Western blot analysis of total cellular p-AKT and AKT1 expression 
• WST-1 assay to determine cellular proliferation rate 
 
Statistical analysis  
 Western blot analysis was repeated at least three times.  All the data were expressed as means ± standard deviation (SD) and subjected to 
analysis of variance (ANOVA) followed by Student t-test for unpaired samples.  A value of p < 0.05 was considered as statistically significant.  
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Figure 3:  Effects of UV exposed photoinitiators on cell viability of 
HN4 cells  
The cell culture media were first mixed with different concentrations of 
Eosin Y (A), Irgacure 2959 (B) or DMPA (C) and then the mixtures were 
exposed to the longwave UV at 365 nm with an intensity of 100 watts for 
30 min.  After the UV exposure, the mixtures were immediately introduced 
to HN4 cells for 0, 1 and 2 days of treatment.  The cell viabilities were 
measured by WST-1 assay at the end of the treatment.  The bars are 
mean ± standard deviation and the symbol * represents statistical 
significance (p < 0.05).   
 
Figure 4:  Effects of UV exposed photoinitiators on AKT activation in HN4 
cells  
The cell culture media were first mixed with different concentrations of Eosin Y, 
Irgacure 2959 or DMPA and then the mixtures were exposed to the longwave UV 
at 365 nm with an intensity of 100 watts for 30 min.  After the UV exposure, the 
mixtures were immediately introduced to HN4 cells for 30 min treatment and the 
total cell lysates were harvested.  The intracellular phospho-AKT (p-AKT) and total 
AKT levels were analyzed by Western blot analysis.  Each positive band was 
normalized to β-actin and was quantified by NIH ImageJ.  The data represents one 
of three standard examples of these experiments.  Each value represents mean ± 
standard deviation and the symbol * represents statistical significance (p < 0.05). 
Figure 5:  Effects of free radicals introduced by the UV exposure of 
Eosin Y on cell viability of HN4 cells  
The cell culture media were first mixed with Eosin Y to reach a final 
concentration of 20 μl/ml and the mixtures were exposed to the longwave 
UV at 365 nm with an intensity of 100 watts for 30 min.  After the UV 
exposure, the mixtures were stored in the dark for 0, 6, 24 and 48 hrs 
before the cell treatment.  HN4 cells were then treated with no addition 
(NA), 20 μl/ml of Eosin Y without UV exposure or the UV exposed 
mixtures for 2 days.  The cell viabilities were measured by WST-1 assay 
at the end of the treatment.  The bars are mean ± standard deviation and 
the symbol * represents statistical significance (p < 0.05).   
Figure 6:  Effects of free radicals introduced by the UV exposure of Eosin Y 
on AKT activation in HN4 cells  
The cell culture media were first mixed with Eosin Y to reach a final concentration 
of 20 μl/ml and the mixtures were exposed to the longwave UV at 365 nm with an 
intensity of 100 watts for 30 min.  After the UV exposure, the mixtures were stored 
in the dark for 0, 6, 24 and 48 hrs before the cell treatment.  HN4 cells were then 
treated with no addition (NA), 20 μl/ml of Eosin Y without UV exposure or the UV 
exposed mixtures for for 30 min and the total cell lysates were harvested.  The 
intracellular phospho-AKT (p-AKT) and total AKT levels were analyzed by Western 
blot analysis.  Each positive band was normalized to β-actin and was quantified by 
NIH ImageJ.  The data represents one of three standard examples of these 
experiments.  Each value represents mean ± standard deviation and the symbol * 
represents statistical significance (p < 0.05). 
MATERIALS 
 
1-vinyl-2 pyrrolidinone (NVP), dimethoxyphenyl acetophone (DMPA), Dimethyl 
sulfoxide (DMSO), eosin Y, ethanol, phosphate buffer solution (PBS), and 
triethanolamine (TEOA) were purchased from Sigma-Aldrich (St. Louis, MO).  
Irgacure 2959 was provided by Ciba Corporation (Newport, DE).  Cell proliferation 
reagent WST-1 was purchased from Roche Applied Science (Indianapolis, IN).  
Phospho-Akt (Ser473) (p-AKT) antibody was purchased from Cell Signaling 
Technology (Danvers, MA).  AKT1 (559028) antibody was purchased from BD 
Biosciences Pharmingen (Mississauga, ON, Canada).  β-actin (ACTBD11B7) 
antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA).  Goat anti-
rabbit antibody conjugated to horseradish peroxidase and goat anti-mouse antibody 
conjugated to horseradish peroxidase were purchased from Bio-Rad (Hercules, CA). 
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Figure 1:  Effects of photoinitiators on cell viability of HN4 cells 
HN4 cells were plated at a density of 1×104 cells/well into 96-well plates and 
treated with different concentrations of Eosin Y (A), Irgacure 2959 (B) or DMPA 
(C) as indicated for 0, 1, 2, 3 and 4 days.  The cell viabilities were measured by 
WST-1 assay at the end of the treatment.  The bars are mean ± standard 
deviation and the symbol * represents statistical significance (p < 0.05).  
Figure 2:  Effects of Eosin Y, Irgacure 2959, and DMPA on AKT activation in 
HN4 cells  
HN4 cells were treated with different concentrations of Eosin Y, Irgacure 2959, 
and DMPA for 30 min as indicated and the total cell lysates were harvested.  The 
intracellular phospho-AKT (p-AKT) and total AKT levels were analyzed by 
Western blot analysis.  Each positive band was normalized to β-actin and was 
quantified by NIH ImageJ.  The data represents one of three standard examples 
of these experiments.  Each value represents mean ± standard deviation and the 
symbol * represents statistical significance (p < 0.05).  
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